Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | DAWN |
---|---|---|
09:32 ET | 59697 | 15.65 |
09:34 ET | 26552 | 15.51 |
09:36 ET | 13514 | 15.475 |
09:38 ET | 61372 | 14.96 |
09:39 ET | 38871 | 15 |
09:41 ET | 9026 | 15.1 |
09:43 ET | 34102 | 14.72 |
09:45 ET | 96688 | 14.45 |
09:48 ET | 38777 | 14.44 |
09:50 ET | 45817 | 14.26 |
09:52 ET | 44426 | 14.525 |
09:54 ET | 49934 | 14.59 |
09:56 ET | 69909 | 14.62 |
09:57 ET | 10413 | 14.66 |
09:59 ET | 15903 | 14.82 |
10:01 ET | 22419 | 14.62 |
10:03 ET | 14592 | 14.649 |
10:06 ET | 30182 | 14.7 |
10:08 ET | 51672 | 14.7 |
10:10 ET | 29525 | 15.07 |
10:12 ET | 57449 | 15.43 |
10:14 ET | 20106 | 15.38 |
10:15 ET | 17569 | 15.36 |
10:17 ET | 13758 | 15.2071 |
10:19 ET | 37872 | 15.23 |
10:21 ET | 32732 | 15.35 |
10:24 ET | 39692 | 15.43 |
10:26 ET | 4400 | 15.455 |
10:28 ET | 4868 | 15.39 |
10:30 ET | 12335 | 15.405 |
10:32 ET | 12899 | 15.3505 |
10:33 ET | 20012 | 15.42 |
10:35 ET | 7546 | 15.35 |
10:37 ET | 32877 | 15.28 |
10:39 ET | 14832 | 15.22 |
10:42 ET | 12803 | 15.16 |
10:44 ET | 5465 | 15.15 |
10:46 ET | 5712 | 14.975 |
10:48 ET | 21999 | 14.89 |
10:50 ET | 5788 | 14.88 |
10:51 ET | 12685 | 14.935 |
10:53 ET | 17019 | 15 |
10:55 ET | 2666 | 15.05 |
10:57 ET | 5670 | 15.035 |
11:00 ET | 2017 | 15.025 |
11:02 ET | 1200 | 15.015 |
11:04 ET | 12949 | 15 |
11:06 ET | 6006 | 14.99 |
11:08 ET | 4549 | 14.97 |
11:09 ET | 3274 | 15.015 |
11:11 ET | 6144 | 14.99 |
11:13 ET | 2901 | 14.92 |
11:15 ET | 7100 | 14.955 |
11:18 ET | 1550 | 14.89 |
11:20 ET | 4743 | 14.93 |
11:22 ET | 9242 | 14.9 |
11:24 ET | 1600 | 14.93 |
11:26 ET | 8166 | 14.85 |
11:27 ET | 4900 | 14.865 |
11:29 ET | 2992 | 14.96 |
11:31 ET | 7400 | 15 |
11:33 ET | 4630 | 15 |
11:36 ET | 4466 | 14.98 |
11:38 ET | 4736 | 15.01 |
11:40 ET | 7117 | 14.97 |
11:42 ET | 3469 | 14.95 |
11:44 ET | 8344 | 14.81 |
11:45 ET | 1992 | 14.82 |
11:47 ET | 33317 | 14.75 |
11:49 ET | 9151 | 14.81 |
11:51 ET | 2951 | 14.81 |
11:54 ET | 5400 | 14.78 |
11:56 ET | 3597 | 14.76 |
11:58 ET | 3826 | 14.77 |
12:00 ET | 3244 | 14.72 |
12:02 ET | 4503 | 14.725 |
12:03 ET | 7565 | 14.75 |
12:05 ET | 7848 | 14.77 |
12:07 ET | 5175 | 14.75 |
12:09 ET | 8334 | 14.73 |
12:12 ET | 11531 | 14.585 |
12:14 ET | 8751 | 14.61 |
12:16 ET | 61744 | 14.7 |
12:18 ET | 7551 | 14.745 |
12:20 ET | 1627 | 14.745 |
12:21 ET | 2220 | 14.82 |
12:23 ET | 2426 | 14.815 |
12:25 ET | 7636 | 14.84 |
12:27 ET | 11713 | 14.735 |
12:30 ET | 5331 | 14.67 |
12:32 ET | 4450 | 14.74 |
12:34 ET | 1602 | 14.74 |
12:36 ET | 3685 | 14.735 |
12:38 ET | 4198 | 14.725 |
12:39 ET | 7562 | 14.685 |
12:41 ET | 4430 | 14.695 |
12:43 ET | 5854 | 14.59 |
12:45 ET | 1747 | 14.64 |
12:48 ET | 7427 | 14.62 |
12:50 ET | 900 | 14.61 |
12:52 ET | 1500 | 14.665 |
12:54 ET | 986 | 14.66 |
12:56 ET | 3806 | 14.67 |
12:57 ET | 2150 | 14.66 |
12:59 ET | 6546 | 14.66 |
01:01 ET | 3227 | 14.66 |
01:03 ET | 2661 | 14.64 |
01:06 ET | 2612 | 14.64 |
01:08 ET | 12849 | 14.645 |
01:10 ET | 6934 | 14.63 |
01:12 ET | 7580 | 14.7 |
01:14 ET | 3000 | 14.56 |
01:15 ET | 5251 | 14.635 |
01:17 ET | 213211 | 14.745 |
01:19 ET | 6319 | 14.9832 |
01:21 ET | 8839 | 14.92 |
01:24 ET | 4100 | 14.98 |
01:26 ET | 6913 | 15.025 |
01:28 ET | 11026 | 15.005 |
01:30 ET | 2808 | 15.01 |
01:32 ET | 1797 | 14.96 |
01:33 ET | 11454 | 15.005 |
01:35 ET | 5128 | 15.01 |
01:37 ET | 11235 | 14.94 |
01:39 ET | 5521 | 14.915 |
01:42 ET | 4579 | 14.85 |
01:44 ET | 3532 | 14.9 |
01:46 ET | 5529 | 14.91 |
01:48 ET | 3280 | 14.91 |
01:50 ET | 6782 | 14.89 |
01:51 ET | 4580 | 14.95 |
01:53 ET | 10001 | 14.94 |
01:55 ET | 17157 | 14.935 |
01:57 ET | 7919 | 14.95 |
02:00 ET | 33413 | 14.95 |
02:02 ET | 4993 | 14.94 |
02:04 ET | 3250 | 14.95 |
02:06 ET | 28157 | 14.985 |
02:08 ET | 9853 | 14.985 |
02:09 ET | 84729 | 15.11 |
02:11 ET | 6987 | 15.05 |
02:13 ET | 20066 | 14.94 |
02:15 ET | 10703 | 14.91 |
02:18 ET | 7910 | 14.94 |
02:20 ET | 28735 | 14.95 |
02:22 ET | 79230 | 15.03 |
02:24 ET | 26954 | 14.97 |
02:26 ET | 32066 | 14.86 |
02:27 ET | 8506 | 14.885 |
02:29 ET | 4180 | 14.8 |
02:31 ET | 4487 | 14.81 |
02:33 ET | 6190 | 14.77 |
02:36 ET | 1000 | 14.815 |
02:38 ET | 7714 | 14.745 |
02:40 ET | 4700 | 14.74 |
02:42 ET | 9061 | 14.69 |
02:44 ET | 25411 | 14.63 |
02:45 ET | 4500 | 14.67 |
02:47 ET | 8423 | 14.68 |
02:49 ET | 14366 | 14.69 |
02:51 ET | 4154 | 14.73 |
02:54 ET | 3891 | 14.79 |
02:56 ET | 3100 | 14.745 |
02:58 ET | 4709 | 14.74 |
03:00 ET | 4696 | 14.7 |
03:02 ET | 5499 | 14.68 |
03:03 ET | 4257 | 14.68 |
03:05 ET | 2672 | 14.65 |
03:07 ET | 7499 | 14.65 |
03:09 ET | 5090 | 14.59 |
03:12 ET | 7504 | 14.56 |
03:14 ET | 8134 | 14.55 |
03:16 ET | 2718 | 14.625 |
03:18 ET | 6952 | 14.6 |
03:20 ET | 12356 | 14.59 |
03:21 ET | 4005 | 14.58 |
03:23 ET | 6058 | 14.51 |
03:25 ET | 11133 | 14.515 |
03:27 ET | 14484 | 14.54 |
03:30 ET | 7847 | 14.55 |
03:32 ET | 2645 | 14.55 |
03:34 ET | 6769 | 14.6 |
03:36 ET | 7376 | 14.57 |
03:38 ET | 7788 | 14.615 |
03:39 ET | 6072 | 14.62 |
03:41 ET | 13214 | 14.51 |
03:43 ET | 18761 | 14.53 |
03:45 ET | 8508 | 14.56 |
03:48 ET | 10262 | 14.59 |
03:50 ET | 14740 | 14.7 |
03:52 ET | 31329 | 14.69 |
03:54 ET | 26256 | 14.63 |
03:56 ET | 30921 | 14.69 |
03:57 ET | 54351 | 14.715 |
03:59 ET | 409823 | 14.71 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Day One Biopharmaceuticals Inc | 1.4B | -7.6x | --- |
Pharvaris NV | 1.3B | -9.6x | --- |
ARS Pharmaceuticals Inc | 1.4B | -31.6x | --- |
Disc Medicine Inc | 1.4B | -12.2x | --- |
Enliven Therapeutics Inc | 1.3B | -14.4x | --- |
Cogent Biosciences Inc | 1.3B | -4.6x | --- |
Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for people of all ages with life-threatening diseases. The Company partners with clinical oncologists, families, and scientists to identify, acquire, and develop cancer treatments. Its product candidates include tovorafenib, pimasertib and the VRK1 program. The Company’s lead product candidate, tovorafenib, is an investigational, oral, brain-penetrant, highly selective type II RAF kinase inhibitor. The Company’s pipeline also includes pimasertib, an investigational, oral, highly selective small molecule inhibitor of mitogen-activated protein kinases 1 and 2 (MEK-1/-2). It has initiated an open-label, multicenter, phase Ib/IIa umbrella master trial, or FIRELIGHT-1, of tovorafenib as a monotherapy or in combination, which consists of two substudies. Substudy 1 is a phase IIa trial of tovorafenib as a monotherapy in patients 12 years and older.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $8.2M |
Shares Outstanding | 98.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.52 |
EPS | $-1.94 |
Book Value | $3.97 |
P/E Ratio | -7.6x |
Price/Sales (TTM) | 173.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,252.55% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.